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Edited by Berend WieringaAbstract We previously reported that expression of myotonic
dystrophy (DM1) expanded CUG repeats impedes NGF-induced
diﬀerentiation in a PC12 clone (CTG90 cells). Here, we present
evidence for changes in the fractional contribution of distinct
voltage-gated Ca2+ channels, key elements in neurotrophin-pro-
moted diﬀerentiation, to the total Ca2+ current in the CTG90
cells. Patch-clamp recordings showed that the relative proportion
of pharmacologically isolated Ca2+ channel types diﬀered be-
tween control and CTG90 cells. Particularly, the functional
expression of N-type channels was signiﬁcantly reduced. Though
quantitative real-time RT-PCR revealed that transcripts for the
pore-forming subunit encoding the N-type channels remained un-
changed, the protein level analyzed by semi-quantitative Western
blotting was down-regulated in the CTG90 cells. These data sug-
gest modiﬁcations in the processing of N-type Ca2+ channels in
PC12 cells expressing the DM1 mutation.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Expansion of CTG trinucleotide repeats has found to be
associated with several neurodegenerative disorders [1]. In par-
ticular, it is known that a CTG triplet expansion within the 3 0-
untranslated region of the myotonin protein kinase (DMPK)
gene on chromosome 19 is the genetic basis of myotonic dystro-
phy type 1 (DM1) [2–6], the most common form of adult onset
muscular dystrophy [4]. Although several studies have sug-
gested the presence of central nervous system (CNS) involve-
ment manifested as cognitive impairment and mental
retardation in DM1 [6–8], it is unclear how expanded CTG
repeats in DMPKmight contribute to these clinical features [6].*Corresponding author. Address: Departamento de Biologı´a Celular,
Cinvestav-IPN, Avenida IPN 2508, Colonia Zacatenco, Me´xico D.F.,
CP 07300, Me´xico. Fax: +5255 50 61 33 93.
E-mail address: rfelix@ﬁsio.cinvestav.mx (R. Felix).
1These authors contributed equally to this work.
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.08.020In a previous report, using a rat pheochromocytoma PC12
clonal cell line stably expressing DM1 expanded CUG repeats
(CTG90 cells), we have shown that this mutation also aﬀect
neuronal function. Notably, CTG90 cells displayed normal
growth when maintained in standard culture conditions, how-
ever, after six days of treatment with nerve growth factor
(NGF), CTG90 cells did not respond with the features that
normally accompany diﬀerentiation of control PC12 cells, sug-
gesting that the mutation interferes with the NGF-induced
diﬀerentiation process [9,10]. It is worth mentioning that when
cultured under standard conditions, PC12 cells resemble adre-
nal chromaﬃn cells in morphology, physiology and biochem-
istry. However, when cultured in the presence of NGF or
other neurotrophic factors, PC12 cells diﬀerentiate to resemble
sympathetic neurons [11,12].
Diﬀerentiation and the resultant physiological and biochem-
ical changes are some of the most useful features of the PC12
cell line. These cells release, depending on the conditions,
dopamine, norepinephrine and acetylcholine, and contain
Na+, K+ and Ca2+ channels and other membrane proteins,
including receptors coupled to G-proteins. Moreover, the rela-
tive proportion of various subtypes of voltage-gated Ca2+
(CaV) channels changes during NGF-promoted diﬀerentiation
of PC12 cells [11,12]. CaV channels are transmembrane pro-
teins that open in response to membrane depolarization and
allow Ca2+ ions to enter the cell from the extracellular space.
By controlling transient rises of intracellular Ca2+, CaV chan-
nels trigger or regulate diverse physiological events, including
neurotransmission, gene expression and cell diﬀerentiation.
CaV channels have been subdivided according to their electro-
physiological properties into: (i) low voltage-activated (LVA
or T-type) channels, and (ii) high-voltage activated (HVA)
channels, a class that includes the L-, N-, P/Q-, and R-types
[13–15].
It has been shown that undiﬀerentiated PC12 cells show a
predominant fraction of L-type CaV channels, and a smaller
component of neuronal N-type x-Conotoxin GVIA (x-Ctx
GVIA)-sensitive channels. Interestingly, chronic application
of NGF signiﬁcantly increases the fraction of functional neu-
ronal N-type channels in the plasma membrane of the PC12
cells [16–20]. In contrast, treatment with inhibitors of protein
kinases blocks NGF-induced diﬀerentiation of PC12 cells
and prevents the up-regulation of N-type CaV channel func-
tional expression caused by this growth factor [17,19].blished by Elsevier B.V. All rights reserved.
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lated CTG triplet expansion in the DMPK gene may inhibit
the expression of neuronal N-type CaV channels in PC12 cells.
This change may help to explain the lack of neurite outgrowth
upon the induction with NGF of CTG90 cells and might con-
tribute to explain some CNS clinical manifestations in DM1.2. Materials and methods
2.1. Cell culture
The experiments were performed on rat pheochromocytoma (PC12)
cells transfected with an empty vector (mock transfected) or stably
expressing DM1 expanded CUG repeats (CTG90 cells) prepared as
previously described [9,10]. It is worth noting that cells transfected
with the empty vector represent excellent controls for the experiments
presented in the current report, given that in previous studies [9,10], in
addition to these cells we have also used cells stably expressing ﬁve
CTG repeats (as controls) and have found no apparent diﬀerences be-
tween both cell lines. Cells were grown in RPMI-1640 culture medium
supplemented with 10% heat-inactivated horse serum, 5% fetal bovine
serum, 100 U of penicillin, and 0.1 mg/ml of streptomycin, at 37 C in
a 5% CO2–95% air humidiﬁed atmosphere. Cells were seeded onto col-
lagen-coated glass coverslips (3 · 9 mm) for electrophysiology, or 60-
mm Petri dishes for protein and RNA extraction. Diﬀerentiation was
induced by treating the cells with 50 ng/ml of mouse Nerve Growth
Factor 2.5S (Alomone Labs) for 6 d. Medium containing NGF was
replenish every two days.
2.2. RNA extraction and reverse transcription polymerase chain reaction
(RT-PCR)
Total RNA was extracted from mock transfected and CTG90 cells
by TRIzol reagent (Invitrogen). Total RNA concentration and purity
were determined spectrophotometrically at O.D. 260/280 nm. For
cDNA synthesis, 5 lg of total RNA were primed with random hexade-
oxynucleotides and reverse transcribed using 2 units of M-MLV re-
verse transcriptase (Invitrogen). Speciﬁc primers to amplify the CTG
tract within 3 0 region of the DMPK gene were used [9,20], primer se-
quences were: CTG-forward 5 0-GAAGGGTCCTTGTAGCCGG-
GAA-3 0 and CTG-reverse 5 0-GGAGGATGGAACACGGACGG-3 0.
PCR reactions containing 5 ll of cDNA, 20 mM Tris–HCl (pH 8.4),
50 mMKCl, 1.5 mMMgCl2, 2.5 lM of each dNTP, 200 ng of each oli-
gonucleotide, and 2.5 units of Taq DNA polymerase in a total volume
of 50 ll were performed in a Gene Amp PCR system 2400 thermal cy-
cler (Applied Biosystems) by using a ‘‘Hot-start’’ protocol. Typically,
30 cycles of ampliﬁcation were performed: denaturing for 30 s at
94 C, annealing for 30 s at 62 C and extension for 30 s at 72 C.
PCR products were separated by electrophoresis in a 1.0% agarose
gel and visualized with ethidium bromide staining using a UVP-
TM12 transilluminator (UVP). Image acquisition was carried out
using the Kodak digital Science 1D v. 2.0 program.
2.3. Electrophysiology
After 6 d in culture, cells were subjected to the standard whole cell
patch-clamp technique using an Axopatch 200B ampliﬁer (Molecular
Devices) as described previously [22]. Current signals were ﬁltered at
2 kHz, digitized at 5.71 kHz and analyzed with pClamp software
(Molecular Devices). Data were leak subtracted on line by a standard
P/4 protocol. Membrane capacitance (Cm) was determined as described
previously [23] and used to normalize currents. The bath recording
solution contained (in mM) 10 BaCl2, 125 TEA-Cl, 10 HEPES andTable 1
Sets of primers designed to amplify rat HVA CaV channel genes from PC12
Gene Forward primer Reverse
Cacna1A CAGCAGAGAACCAGAGGAGAAG GAGGCT
Cacna1B GCCAACAGCGGCACTAGA TGCTAG
Cacna1C CCGGAAGCCAGTGCATTTT GTTGGT
Cacna1D CATCCGAAGAGCCTGCATTAGTATA CTAAGG15 glucose (pH 7.3). The internal solution consisted of (in mM) 110
CsCl, 5 MgCl2, 10 EGTA, 10 HEPES, 4 Na-ATP and 0.1 GTP (pH
7.3). x-Ctx GVIA (Alomone Labs) and nitrendipine (Sigma Chemical
Co.) were prepared as a 100 lM and 10 mM stock, in distilled water
and DMSO, respectively, aliquoted and stored at 20 C. A fresh ali-
quot was diluted in the bath solution for each experiment to give a ﬁnal
concentration of 1 lM (x-Ctx GVIA) and 10 lM (nitrendipine). All
experiments were performed at room temperature (22 C).
2.4. Real-time RT-PCR
The mRNA levels of the rat CaV ion-conducting subunits CaV1.2
(formerly a1C; GenBank accession number NM_012517), CaV1.3
(a1D; NM_017298), CaV2.1 (a1A; NM_012918) and CaV2.2 (a1B;
AF055477), were measured by quantitative RT-PCR assay as previ-
ously described [10]. Brieﬂy, 1 lg of total RNA was primed with ran-
dom hexanucleotides and reverse transcribed by M-MLV transcriptase
(Invitrogen), according to the manufacturer’s instructions. The primers
and probes (Table 1) for CaV channel subunit analyses were from
Applied Biosystems. PCR reactions were performed using the TaqMan
Universal PCR Master Mix (Perkin Elmer) in a total volume of 25 ll
containing 400 nM of each oligonucleotide, 200 nM of the TaqMan
probe, and 3 ll of cDNA. Reactions were carried out in 96-well plates
on a 7000 Sequence Detector (Perkin–Elmer). The PCR cycling condi-
tions included an initial step at 50 C for 2 min and 95 C for 10 min,
followed by 40 cycles of 98 C for 15 s and a ﬁnal step of 60 C for
1 min. The expression of the eukaryotic 18S ribosomal RNA (r18S)
gene was analyzed as endogenous control.
2.5. Western blot analysis
Control and NGF-treated cell cultures were removed from collagen-
coated dishes, washed with PBS pH 7.4 (137 mM NaCl, 2.7 mM KCl,
10.1 mM Na2HPO4, 1.8 mM KH2PO4) and suspended in triple-deter-
gent lysis buﬀer containing proteases inhibitors (50 mM Tris–HCl
pH 8.0, 150 mM NaCl, 0.1% SDS, 1.0% NP-40, 0.5% sodium deoxy-
cholate, 1 mM PMSF, complete 1X; Roche Diagnostics). The extracts
were centrifuged to remove insoluble debris and protein concentrations
in the supernatants were determined using a Bio-Rad protein assay.
Volumes corresponding to 50 lg of protein were mixed with sample
buﬀer (50 mM Tris–HCl [pH 6.8], 2% SDS, 10% glycerol, 5% b-
mercaptoethanol, 0.01% bromofenol blue) and boiled for 5 min. Pro-
teins were resolved in 10% SDS–polyacrylamide gels and transferred
to nitrocellulose membranes (Amersham Biosciences). After blocking
with 6% non-fat dry milk in TBS-T (10 mM Tris–HCl, 0.15 M NaCl,
0.05% tween 20), membranes were incubated overnight with the pri-
mary anti-CaV2.2 antibody (Alomone Labs) (1:500 in TBS-T with
3% non-fat milk). Membranes were then washed and incubated with
horseradish peroxidase goat anti-rabbit secondary antibody (Zymed)
diluted in TBS-T with 3% non-fat dry milk and developed with the
ECL reagent (Amersham Biosciences). As a protein loading control,
membranes were striped and incubated with a mouse monoclonal
anti-b-actin antibody. Semi-quantitative analysis was carried out by
densitometry using the Kodak digital Science ID v.2.0 system pro-
gram.
2.6. Data analysis
The data are given as mean ± S.E. Statistical diﬀerences between two
means were determined by Student’s t tests (P < 0.05). Steady-state
inactivation curves were ﬁtted with a Boltzmann function: IBa = Imax/
(1 + exp[(Vm  V1/2)/k]), where the current amplitude IBa has
decreased to a half-amplitude at V1/2 with an e-fold change over k
mV [21]. Cell surface area was estimated from the whole-cell capaci-
tance measurements assuming that Cm = 1 lF/cm
2 [13,23]. The diﬀer-
entiation score was estimated as previously described [9,10,24].cells
primer Taqman probe
GAGCGCTTCATG CAGAGATGGTACTGAGGTTAT
CACCAGATGTTGACAT CACCCGCAGGGCAGT
GAAGATCGTGTCATTGAC CCAAACAACAGGTTCCG
CCACACAATTGGCAAAA TCAAATGGTTTCCAATCCAC
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Although this study is based upon the CTG90 stably-trans-
fected PC12 cell line established in our laboratory [9,10], be-
fore investigating the eﬀects of the expanded CTG repeat in
the 3 0-untranslated region of the DMPK gene on Ca2+ channel
expression, it was necessary to obtain evidence for the expres-
sion of the 90 CTG repeats in the population of cells used in
this particular study. To this end, we decided to use a combi-
nation of RT-PCR and the previously deﬁned ‘diﬀerentiation
score’ as indicators that the repeats are maintained and
expressed in the transfected PC12 cells. Fig. 1A shows the
analysis by RT-PCR of stable clones expressing the CTG
repeats, using primers ﬂanking the CTG repeat region. The
expected fragment of 405 bp [9] was obtained for the ampliﬁ-
cation of the CTG90 stable clones and the vector used in the
transfections. The absence of RT-PCR product from the
cDNA obtained from cells transfected with the empty vector
conﬁrmed the speciﬁcity of the assay. Likewise, measurement
of neurite outgrowth conﬁrmed that the CTG90 cells did not
respond to NGF with the features that accompanied diﬀeren-
tiation of control PC12 cells (Fig. 1B). As can be seen in
Fig. 1C, a 78% reduction in the diﬀerentiation score was
observed in the CTG90 cell line in comparison to PC12 cells
transfected with the empty vector. These results conﬁrmed that
the CTG90 cells used in the present studies express the DM1
expanded repeats and display the abnormal response to
NGF treatment reported previously [9].Fig. 1. Expression of the expanded CUG repeats and inhibition of neuronal
(A) RT-PCR analysis of the CTG repeat region, showing the expression of t
marker (100 bp ladder, Invitrogen); the second lane is the vector (pcDNA3/
reactions ran without reverse transcriptase. Expression of GAPDH gene
representative ﬁelds, showing typical morphologies of control and CTG90 cel
and CTG90 cells calculated based on the relative lengths of the neurites. A
CTG90 cells.To assess whether the altered response of CTG90 PC12-de-
rived cell line to NGF is associated with a modiﬁcation of CaV
channel expression, we initially compared capacitative and
ionic macroscopic currents (using Ba2+ as charge carrier) in
mock transfected and CTG90 cells exposed to the neurotro-
phic factor for 6 d. Mock transfected PC12 cells in standard
culture conditions assumed a spherical shape and showed
reduced membrane capacitance (Cm; an index of the total plas-
ma membrane area), whereas those incubated in presence of
50 ng/ml NGF became ﬂattened with apparent neurite out-
growth and increased total plasma membrane area (Fig. 2A).
In contrast, the membrane surface area of the NGF-treated
CTG90 cells was signiﬁcantly smaller than that in the mock
transfected cells, corroborating the reduced sensitivity of this
PC12-derived clone to the neuritogenic eﬀect of the growth
factor (Fig. 2A).
Whole cell patch-clamp analysis of Ba2+ currents through
CaV channels was next performed. As reported previously,
undiﬀerentiated PC12 cells showed currents with low ampli-
tude [16,22], but NGF treatment caused an approximately
twofold increase in current magnitude (not shown). Examples
of current traces recorded from NGF-treated mock transfected
and CTG90 cells obtained with 140 ms test pulses (to +10 mV)
from a holding potential (HP) of 80 mV are shown in
Fig. 2B. As can be seen, the peak amplitude of the currents
was similar in both cell types; however, when the current
amplitude was normalized to plasma membrane area, the
resulting current density of CTG90 cells was larger than thatoutgrowth in the PC12 cells expressing DM1 expanded CUG repeats.
he 90 repeats in the CTG90 cells. The ﬁrst lane is the molecular weight
CTG90/CAT) used as a control of the CTG90 tract size; –RT denotes
was used as a positive control. (B) Phase contrast photographs of
ls after 6 d of treatment with NGF. (C) Diﬀerentiation score of control
sterisk denotes signiﬁcant diﬀerences (P < 0.05) between control and
Fig. 2. Eﬀect of DM1 expanded CUG repeats on cell size and CaV channel activity. (A) Comparison of cell surface area estimated from the
capacitance measurements in mock transfected and CTG90 cells (see Methods). The number of recorded cells is given in parenthesis. The asterisks
denote signiﬁcant diﬀerences (P < 0.05). (B) Representative superimposed current traces recorded from mock transfected (control) and CTG90 cells.
The currents shown were elicited by applying 140 ms pulses to +10 mV from a HP of 80 mV. (C) Maximal peak current amplitudes were
normalized to whole cell capacitance to give current densities in pA/pF. Bars show mean ± S.E.M. current density at +10 mV for the indicated
condition. (D) Peak current density–voltage relationships for mock transfected and CTG90 cells.
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sured at +10 mV was 4.7 ± 0.6 pA/pF in mock transfected
cells and 7.3 ± 0.9 pA/pF in the CTG90 cells, with a net cur-
rent density increment of 55% (Fig. 2C). The mean results of
the current density–voltage relationships showed an activation
threshold at 20 mV and a peak at +10 mV in both cell
types, with an increase in current density within a wide range
of test potentials in the CTG90 cells as a result of the diﬀer-
ences in Cm (Fig. 2D).
Likewise, the waveform of the currents was diﬀerent in mock
transfected and CTG90 cells after NGF treatment (Fig. 2B).
The percentage of current inactivated after 140 ms with respect
to the peak current amplitude (IBa remaining) was signiﬁcantly
larger in the CTG90 cells (87 ± 3%) when compared with the
mock transfected cells (61 ± 4%) (Fig. 3A). This result revealed
potential changes in the fractional contribution of CaV
channels with distinct kinetics of inactivation to the whole-cell
current. In functional terms, the decrease in the strength of
time-dependent inactivation may indicate a decreased contri-
bution of inactivating channels. It is noteworthy that neuronal
N- (as well as P/Q-type) channels inactivates 6–10 times faster
than the long-lasting L-type channels [13].The voltage dependence of current inactivation was also
compared for mock transfected versus CTG90 cells, using a
typical double-pulse protocol, wherein a 4 s conditioning pulse
to various potentials (110 to +50 mV) was followed by test
steps to +10 mV. The result of this analysis showed that the
midpoint of the steady-state inactivation curve was shifted
8 mV to the depolarizing direction in the CTG90 cells com-
pared to the mock transfected PC12 cells (Fig. 3B). More
importantly, this change was not a gradual parallel rightward
shift of inactivation curves; instead, the inactivation curve in
the CTG90 cells exhibited a less prominent component of inac-
tivating channels at voltages >30 mV. The inactivating com-
ponents at +10 mV, induced by the 4 s conditioning prepulse,
accounted for 90% and 73% of the total currents for mock
transfected and CTG90 cells, respectively (Fig. 3C).
The above mentioned changes are consistent with reduced
expression of functional inactivating (neuronal, N-type) chan-
nels in the NGF-treated CTG90 cells. To test this hypothesis,
we next evaluated the Ca2+ current components in mock trans-
fected and CTG90 cells using speciﬁc antagonists. Fig. 4A
shows typical superimposed current traces obtained from
mock transfected (upper panel) and CTG90 (lower panel) cells
Fig. 3. DM1 expanded CUG repeat expression alters the inactivation properties of CaV channels. (A) Comparison of the percentage of inactivated
channels at the end of a 140 ms test pulse in mock transfected and CTG90 cells before (open bars) and after (solid bars) a 6 d treatment with NGF.
The number of recorded cells is given in parenthesis. The asterisks denote signiﬁcant diﬀerences (P < 0.05). (B) Normalized, average steady-state
inactivation curves for mock transfected (control) and CTG90 cells after NGF treatment. Symbols denote average and ±S.E.M. of the normalized
data at a given membrane potential for 20–22 diﬀerent cells. Solid lines represent single Boltzmann ﬁts to the averaged data. (C) Comparison of the
inactivating component of the whole cell currents induced by the 4-s prepulse in mock transfected (control) and CTG90 cells after NGF treatment.
Fig. 4. Pharmacologically distinct components of the macroscopic currents through CaV channels in PC12 cells. (A) Superimposed recordings
illustrating the eﬀect of the L-type Ca2+ channel blocker nitrendipine (10 lM) and the N-type Ca2+ channel blocker x-Ctx GVIA (1 lM) on IBa in
mock transfected (upper traces) and CTG90 cells (lower traces). (B) Average data of the eﬀects of the channel blockers on peak IBa. Normalized peak
currents obtained in mock transfected and CTG90 cells applying 140 ms pulses to +10 mV from a HP of 80 mV are compared between treatments.
Values are means ± SE from 12 to 14 cells. The asterisks denote signiﬁcant diﬀerences (P < 0.05) as compared with the untreated cells.
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(nitrendipine) to block L-type Ca2+ currents, and x-Ctx GVIA
to block the N-type component of the current. As can be seen,
mock transfected PC12 cells had a prominent L-type Ca2+ cur-
rent component, and nitrendipine blocked 53 ± 3% of the
whole-cell current. The addition of x-Ctx GVIA caused a fur-
ther blockade of 35 ± 3%, revealing the magnitude of the N-
type component of the current (Fig. 4B). Interestingly, this
combination of channel antagonists did not suppress entirely
the current unveiling the presence of a resistant component
(12 ± 3%) most likely due to the presence of P/Q-type channels[22]. By contrast, in the NGF-treated CTG90 cells the current
carried through N-type channels was drastically reduced (to
11 ± 3%) while the estimated L-type and remaining currents
were increased to 66 ± 5 and 22 ± 4%, respectively.
Important for assessment of the DM1 expanded CUG
repeats eﬀects on CaV channels was an accurate analysis of
the expression pattern for the mRNA coding these proteins
in the CTG90 cells. It is noteworthy that molecular and bio-
chemical studies have shown that HVA channels are oligomeric
complexes formed by a main a1 subunit that is the permeation
pathway of all CaV channels (and is also responsible for binding
Fig. 5. Expression of CaV channel a1 subunits mRNA in the PC12 cells. Quantitative real-time PCR results of CaV1.2 (A), CaV2.1 (B) and CaV2.2
(C) mRNA levels normalized to r18S RNA expression in mock transfected (control) and CTG90 cells are summarized as bar graphs. Cells were
cultured for 6 d in absence and in presence of NGF as indicated. Data from three to ﬁve independent experiments are expressed as fold increase over
the value of untreated control cells. The asterisks denote signiﬁcant diﬀerences (P < 0.05) as compared with untreated cells.
Fig. 6. DM1 expanded CUG repeat expression alters CaV2.2 subunit
protein expression. (A) Total cell extracts from control and CTG90
cells kept in culture in absence and presence of NGF for 6 d were
analyzed by Western-blot using an anti-CaV2.2 speciﬁc antibody.
Membranes were stripped and reprobed with an anti-actin antibody as
a protein loading control. (B) Band signal intensities of CaV2.2 were
normalized to actin levels to obtain the relative expression of the
CaV2.2 subunit. Asterisk denotes signiﬁcant diﬀerences (P < 0.05)
between control and CTG90 cells.
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subunits (a2d, b and c) that modulate the properties of the
Ca2+ currents [13–15]. Molecular cloning has identiﬁed 7 diﬀer-
ent genes coding HVACaV channel a1 subunits (CaV1.1–CaV1.4
and CaV2.1–CaV2.3). We therefore designed primers for four
HVA CaV channel a1 subunit that are believed to underlie
Ca2+ currents in PC12 cells (Table 1) and quantitatively assessed
their levels of expression using real time RT-PCR.
As shown in Fig. 5, CaV1.2, CaV2.1 and CaV2.2 mRNAs are
expressed in control PC12 cells. In contrast, CaV1.3 mRNA
levels were not detectable (not shown). Likewise, no signiﬁcant
changes in steady-state levels of CaV1.2, CaV2.1 and CaV2.2
mRNA were found in CTG90 cells cultured in absence of
NGF, as compared with mock transfected cells. As anticipated
from the observed NGF-induced increase in neuronal Ca2+
currents, the expression of the mRNA for CaV2.1 and
CaV2.2 channel subunits was signiﬁcantly up-regulated in
mock transfected after chronic treatment with the growth fac-
tor (Fig. 5B and C), while the expression of the L-type CaV1.2
subunit remained unaﬀected (Fig. 5A). Interestingly, regula-
tion of the CaV channel mRNA levels was unaltered in the
CTG90 cells after NGF treatment, compared with mock trans-
fected cells. Therefore, the decrease of functional neuronal
channels in the CTG90 cells was not mediated by reduced tran-
scription of the ion conducting CaV2.1 and CaV2.2 channel
subunits.
By using a rabbit polyclonal antibody raised against the
intracellular loop between II and III domains of the CaV2.2
(a1B) subunit (ACC-002, Alomone Labs), we then studied
whether the CTG trinucleotide repeat expansion in the DMPK
gene aﬀect the expression of the N-type Ca2+ channel at the
level of the protein. As can be seen in the upper panel of
Fig. 6A, a 230-kDa band, the expected molecular mass of
rat CaV2.2 [25], was detected in control and CTG90 cells
both in presence and absence of NGF. The relative levels of
the CaV2.2 protein expression were then measured by semi-
quantitative Western blotting experiments and subsequently
analyzed after normalization to those of b-actin (Fig. 6B).
Mean values for the untreated control cells were set at 100%.
Notably, the results of this analysis showed that the expression
of the CaV2.2 protein decreased sharply (50%) in the CTG90
cells.4. Discussion
It is well established that chronic treatment of PC12 cells with
NGF induces sympathetic neuron-like diﬀerentiation, which
involves expression of several types of ion channels including
CaV channels [16,18,19,26]. Indeed, neurite outgrowth of
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resulting from CaV channel activation [27,28], and prevented
by application of CaV channel antagonists [29]. Interestingly,
the CTG90 cells, a subclone of PC12 cells which expresses the
DM1 expanded CUG repeats, display an impaired response
to NGF [9,10] providing an excellent model for studying
disruption of processes associated with neuronal diﬀerentia-
tion. In the current report, we presented evidence that the
DM1 mutation may cause an inhibition in the functional
expression of neuronal N-type CaV channels.
In an initial series of experiments by measuring whole cell
capacitance, we found that the membrane surface area was
increased after exposure to NGF in both mock transfected
and CTG90 cells, though this eﬀect was signiﬁcantly smaller
in the later (Fig. 2A). This result is consistent with previous
data indicating that the number of neurites in PC12 cells
increases drastically after NGF treatment [9,27–29], and indi-
cates that the sensitivity to the neuritogenic eﬀect of NGF is
decreased in the CTG90 cells (Fig. 1B and C).
Using whole cell patch-clamp recording, we next looked at
the eﬀects of the DM1 expanded CUG repeats on CaV channel
expression as reﬂected by changes in current properties. Nota-
bly, a shift of the steady-state inactivation curve towards more
positive potentials as well as a decrease in the strength of time-
dependent inactivation was observed in NGF-treated CTG90
cells compared to the mock transfected cells (Fig. 3), suggest-
ing a reshuﬄing of CaV channels in these cells. These ﬁndings
are consistent with previous data indicating an increase in the
strength of time-dependent inactivation in NGF diﬀerentiated
compared to undiﬀerentiated PC12 cells [30], and with the view
that NGF-promoted diﬀerentiation is accompanied by an in-
creased expression of inactivating N-type CaV channels
[16,18,19,22].
Next, using nitrendipine and x-Ctx GVIA, two speciﬁc CaV
channel antagonists, we observed the presence of three types of
macroscopic currents: nitrendipine-sensitive (L-type), x-Ctx
GVIA-sensitive (N-type) and nitrendipine plus x-Ctx GVIA-
resistant (possibly P/Q-type) current. Interestingly, the presence
of DM1 expanded CUG repeats down-regulated the x-Ctx
GVIA-sensitive current in the CTG90 cells whereas the two
other currents were up-regulated (Fig. 4). Together, these
results suggest that the functional expression of x-Ctx GVIA-
sensitive N-type but not L-type and/or P/Q-type CaV channels
contribute to the eﬀects of NGF on neurite outgrowth during
PC12 cell diﬀerentiation.
Having shown that neurite outgrowth (reﬂected as a reduc-
tion in the cell membrane area) was partially blocked in the
CTG90 cells as a result of a reduced functional expression of
neuronal N-type currents, we sought to determine how NGF
inﬂuences CaV gene expression in these cells. To this end, the
relative levels of the mRNA encoding four distinct pore-form-
ing CaV channel a1 subunit genes were quantiﬁed using real-
time PCR. The results of this analysis showed that in both
mock transfected and CTG90 cells, NGF treatment induced
an important up-regulation (>50%) in the mRNA levels of
CaV2.2 (N-type) neuronal channels, which is in agreement with
previous studies [31]. NGF treatment also resulted in a signif-
icant up-regulation of the CaV2.1 (P/Q-type) channel mRNA
levels. To our knowledge this is the ﬁrst evidence for NGF-
induced changes in the transcript levels of the neuronal
P/Q-type channel in the PC12 cells. In contrast, NGF had
no eﬀect on the mRNA levels of CaV1.2 channels.Unexpectedly, NGF-mediated transcriptional regulation of
CaV2.2 (N-type) was unaltered in the CTG90 cells, as com-
pared with mock transfected cells, suggesting that the decrease
in the functional expression of this type of channels in the cells
expressing DM1 expanded CUG repeats are not due to
reduced transcription of the ion-conducting CaV2.2 subunit.
Instead, changes in the naturally-occurring post-transcrip-
tional processing of the CaV2.2 channel pore-forming subunit
in the CTG90 cells may account for the diﬀerences observed.
Indeed, a signiﬁcant decrease (50%) in the protein levels of
CaV2.2 was found in the CTG90 cells both in the control con-
dition or after NGF treatment (Fig. 6B).
In addition to the direct post-transcriptional control of the
N-type CaV2.2 channel pore-forming subunit, an alternative
mechanism to explain the inhibitory actions of the expanded
CTG repeat on Ca2+ channel expression in PC12 cells could
be altered transcription/translation of the CaV auxiliary sub-
units. In this regard, it is worth mentioning that preliminary
cDNA microarray results in our laboratory indicated that
the expression level of the Cacng2 gene, which encodes for
the CaVc2 auxiliary subunit (also known as stargazing)
[25,32], is increased in the CTG90 cells (not shown). Consistent
with this, semi-quantitative Western blot analysis using speciﬁc
CaVc2 antibodies (sc-18285, Santa Cruz Biotechnology, Inc.)
indicated that the expression of this auxiliary subunit of the
CaV2.2 channels is signiﬁcantly increased in the CTG90 cells
(not shown). Interestingly, changes in the level of CaVc2 have
a signiﬁcant impact on neuronal CaV2.2 subunit expression. In
particular, functional studies have shown that the CaVc2 sub-
unit decreases N-type current amplitude by altering the bio-
physical properties of pre-existing CaV2.2 channels [25,32]
and by suppressing the synthesis of new channels [32]. It is
worth noting that this study provides what is to our knowledge
the ﬁrst evidence for the expression of CaVc2 in PC12 cells.
A second alternative possibility to explain the inhibition of
N-type Ca2+ channel activity by expanded CTG repeat could
be diﬀerential expression of CaV2.2 splice isoforms with
reduced conductance or distinct capability of interaction with
factors (e.g. CaVb subunits) that contribute to setting the time
course of channel inactivation. In this regard, it is noteworthy
that the mammalian CaV2.2 gene is encoded by >50 exons, >10
of which can be alternatively spliced [33–35]. RT-PCR to dis-
criminate between splice isoforms would help establish their
relative contribution.
Although the precise mechanism by which the untranslated
CTG triplet expansion within the DMPK gene may alter ion
channel functional expression is presently unclear, it has been
reported that DM1 may involve a disease mechanism in which
transcripts from the mutant DMPK allele in skeletal muscle
and in brain accumulate in the cell nucleus and compromise
the regulation of alternative splicing [6,36]. Interestingly
enough, Dirksen and colleagues have recently suggested a
model that helps to explain the decrease in the number of
muscle chloride (ClC-1) channels observed in two murine
models of DM1 [37]. According to this model, the reduction
in the number of channels is likely due to aberrant splicing
of the Clcn1 pre-mRNA caused by expression of expanded
CUG repeat-containing mRNA species that sequester muscle-
blind-like 1 (Mbnl1) proteins, normal regulators of mRNA
splicing that bind with high aﬃnity to expanded CUG or
CCUG repeat RNA [36–38]. Loss of Mbnl1-mediated regula-
tion of proper Clcn1 splicing may lead to a reduction in the
A. Andrade et al. / FEBS Letters 581 (2007) 4430–4438 4437level of full-length Clcn1 mRNA and the production of aber-
rantly transcripts encoding truncated proteins that could exert
additional dominant-negative eﬀects on ClC-1 function. These
actions may result in a subsequent reduction in current density
[37]. The possibility exists that an analogue cascade of events
might also occur during Ca2+ channel regulation in the
CTG90 cells. Therefore, testing this hypothesis is an interesting
topic for future studies.
In summary, our ﬁndings provide novel insight into the
mechanisms that regulate neuronal CaV channel expression
during NGF-promoted diﬀerentiation in the PC12 cell line.
In addition, the observed diﬀerential changes in CaV channel
expression may contribute to the suppression of neurite out-
growth upon the induction with NGF in CTG90 cells. Further
characterization of the molecular mechanisms underlying the
defective neurite outgrowth of CTG90 cells might help to
explain the DM1 neuronal manifestations, such as cognitive
impairment or mental retardation.
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